MIF modulates impaired astrocyte distribution in schizophrenia cortical spheroids

Clicks: 2
ID: 314053
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #373 of 378 articles by views in Brain research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 378 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Neuroinflammation and astrocyte dysfunction are associated with schizophrenia. To elucidate the molecular mechanisms involved, we generated induced pluripotent stem cells from 14 schizophrenia patients and 14 healthy controls and differentiated them to human cortical spheroids. Transcriptional profiling revealed overexpression of cilia-related genes in schizophrenia spheroids which was mainly driven by astrocytes. We identified baseline abnormal astrocyte distribution in schizophrenia and show that it is triggered by the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF), primarily secreted by neurons. While treatment with the MIF antagonist ISO-1 attenuated abnormal astrocyte distribution in schizophrenia spheroids and reduced pro-inflammatory cytokines secretion, MIF gene knockout with CRISPR-Cas9 exacerbated astrocyte and cytokines dysregulation in schizophrenia cultures, suggesting that both extremes of elevated and absent MIF lead to impaired astrocyte distribution and that a minimum expression of MIF is required for optimal cell function. Taken together, our results point to a MIF-induced regulation of cortical astroglia in schizophrenia and highlight MIF antagonists as potential novel treatment strategies.
Reference Key
openalex_W7161631014 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jordi Requena Osete, Attila Szabo, Ibrahim A Akkouh, Martin Falck, Oleksandr Ievglevskyi, Matthieu Vandenberghe, Guro Helén Vatne, Hege Brincker Fjerdingstad, Evgeniia Frei, Timothy Hughes, Marianne Fyhn, Olav B Smeland, Nils Eiel Steen, Thor Ueland, Ole A Andreassen, Srdjan Djurovic
Journal Brain research
Year 2026
DOI
10.1093/brain/awag181
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.